Immix Biopharma (IMMX) Exchange Rate Effect (2021 - 2026)
Immix Biopharma's (IMMX) quarterly Exchange Rate Effect came in at -$12813.0 in Q1 2026, down 60.16% year-on-year from -$32163.2 in Q1 2025, and down 9.09% quarter-over-quarter from -$11745.0 in Q4 2025.
Immix Biopharma (IMMX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immix Biopharma has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$12813.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$12813.0, down 60.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$971.0 (up 22.69% YoY), and the FY2025 annual result was $3842.0, up 206.07% from the prior year.
- Exchange Rate Effect came in at -$12813.0 for Q1 2026 at Immix Biopharma, down from -$11745.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $44139.0 in Q2 2025 to a low of -$25128.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$5304.0 (2022), against an average of -$648.53.
- Across the five-year window, Exchange Rate Effect jumped 20028.66% in 2023 and sank 1744.48% in 2024, its largest moves.
- Immix Biopharma's Exchange Rate Effect stood at -$157.0 in 2022, then surged by 20028.66% to $31288.0 in 2023, then sank by 180.31% to -$25128.0 in 2024, then jumped by 53.26% to -$11745.0 in 2025, then fell by 9.09% to -$12813.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$12813.0 (Q1 2026), -$11745.0 (Q4 2025), and -$20552.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | -12,813.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,813.00 |
| Mar 31, 2026 | -12,813.00 |
| Dec 31, 2025 | -11,745.00 |
| Dec 31, 2025 | -11,745.00 |
| Sep 30, 2025 | -20,552.00 |
| Sep 30, 2025 | -20,552.00 |
| Jun 30, 2025 | 44,139.00 |
| Jun 30, 2025 | 44,139.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -25,128.00 |
| Dec 31, 2024 | -25,128.00 |
| Sep 30, 2024 | 22,962.00 |
| Sep 30, 2024 | 22,962.00 |
| Jun 30, 2024 | 8,910.00 |
| Jun 30, 2024 | 8,910.00 |
| Mar 31, 2024 | -10,366.00 |
| Mar 31, 2024 | -10,366.00 |
| Dec 31, 2023 | 31,288.00 |
| Dec 31, 2023 | 31,288.00 |